p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability.

Nat Commun 2020 10 6;11(1):5007. Epub 2020 Oct 6.

Department of Surgery, Section of Neurosurgery, The University of Chicago, Chicago, IL, 60637, USA.

p50, the mature product of NFKB1, is constitutively produced from its precursor, p105. Here, we identify BARD1 as a p50-interacting factor. p50 directly associates with the BARD1 BRCT domains via a C-terminal phospho-serine motif. This interaction is induced by ATR and results in mono-ubiquitination of p50 by the BARD1/BRCA1 complex. During the cell cycle, p50 is mono-ubiquitinated in S phase and loss of this post-translational modification increases S phase progression and chromosomal breakage. Genome-wide studies reveal a substantial decrease in p50 chromatin enrichment in S phase and Cycln E is identified as a factor regulated by p50 during the G1 to S transition. Functionally, interaction with BARD1 promotes p50 protein stability and consistent with this, in human cancer specimens, low nuclear BARD1 protein strongly correlates with low nuclear p50. These data indicate that p50 mono-ubiquitination by BARD1/BRCA1 during the cell cycle regulates S phase progression to maintain genome integrity.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-020-18838-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538584PMC
October 2020

Publication Analysis

Top Keywords

cell cycle
12
p50
10
low nuclear
8
interaction bard1
8
p50 mono-ubiquitination
8
phase progression
8
bard1
5
p50 mono-ubiquitinated
4
phase loss
4
mono-ubiquitinated phase
4
phase
4
post-translational modification
4
increases phase
4
modification increases
4
specimens low
4
loss post-translational
4
bard1/brca1 complex
4
bard1 protein
4
induced atr
4
interaction induced
4

Similar Publications